New Evidence Shows 1 in 10 Women Experience PTSD Symptoms After Induced Vaginal Delivery
How often do women develop posttraumatic stress disorder (PTSD) after an induced labor? A new multicenter French cohort study delivers an answer that deserves attention: about 1 in 10 women screened positive for significant PTSD symptoms two months after induced vaginal delivery.
Study Design: Prospective Multicenter Cohort
Researchers performed an ancillary analysis of the TRAAP randomized trial, which originally investigated tranexamic acid for prevention of postpartum hemorrhage. This study focused on 794 women who underwent labor induction and delivered vaginally at or after 35 weeks’ gestation in 15 French university hospitals. At two months postpartum, women completed validated PTSD symptom questionnaires (IES-R and TES).
Key Findings: PTSD Prevalence and Risk Factors
The corrected prevalence of PTSD symptoms was 10.6% at two months after induced vaginal delivery.
Psychosocial vulnerability increased risk: women with psychiatric history or who were born in Africa had higher odds of postpartum PTSD.
Obstetric factors also played a significant role:
Cervical ripening as the initial induction method doubled PTSD risk (adjusted OR 2.0, 95% CI 1.1–3.6).
Fetal indications for induction (e.g., concerns about fetal wellbeing) increased PTSD risk (adjusted OR 2.6, 95% CI 1.2–5.5).
Postpartum hemorrhage ≥1000 mL was strongly associated with PTSD (adjusted OR 4.9, 95% CI 1.8–13.3).
Women who reported bad memories of delivery on day 2 postpartum were more likely to screen positive for PTSD at two months.
Clinical Implications: Who’s at Risk—and What to Do?
Why does this matter for your practice?
The data highlight specific subgroups—especially women undergoing cervical ripening, those with fetal indications for induction, or who have significant psychosocial vulnerability—as being at higher risk for postpartum PTSD. Additionally, immediate negative childbirth memories and major postpartum hemorrhage are strong warning signs.
Action points:
Consider early screening for PTSD in women with these risk factors.
Offer enhanced counseling and support before and after induction, especially with cervical ripening or fetal indications.
Recognize that even in low-risk, university hospital settings, the mental health risk after induction is not negligible.
Study Strengths and Limitations
This is the largest prospective cohort to specifically address PTSD after induced vaginal delivery. The study featured robust follow-up and validated measures, but results may underestimate PTSD rates due to RCT participation bias. Also, findings may not generalize to non-university or non-French settings.
Conclusion
Postpartum PTSD affects about 1 in 10 women after induced vaginal delivery, with risk magnified by specific induction methods and psychosocial or obstetric factors. Early identification and intervention could improve outcomes for these at-risk mothers.
Key points
About 10% of women report clinically significant PTSD symptoms after induced vaginal delivery.
Cervical ripening and fetal indications for induction are major risk factors for postpartum PTSD.
Women with psychiatric history or born in Africa face higher PTSD risk.
Severe postpartum hemorrhage (≥1000 mL) and negative early birth memories increase PTSD likelihood.
Early screening and targeted support after induction may reduce PTSD burden.
Citation:
Froeliger A, Deneux-Tharaux C, Loussert L, Sutter-Dallay AL, Madar H, Sentilhes L. Posttraumatic stress disorder 2 months after induced vaginal delivery: A multicenter prospective study. Int J Gynecol Obstet. 2026;00:1-13. doi:10.1002/ijgo.71329
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.